Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Bayer announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD ® Centargo CT Injection System, an innovative multi-patient injector that drives workflow ...
Bayer (BAYRY) announced that its MEDRAD Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration to expand the use of compatible contrast agent ...
Bayer, a global enterprise with core competencies in the life science fields of health care and nutrition, announced 510(k) clearance from the US Food and Drug Administration (FDA) for its MEDRAD ...
CHICAGO--(BUSINESS WIRE)--Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline as well as innovations around Artificial Intelligence (AI) and will ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer today announced that its MEDRAD ® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results